I85PREP
⌘ K
CMRE study materials
CMRE study resources

CMRE practice questions

One question at a time. Build your CMRE understanding.

First 50 of 200 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Medical Review Fundamentals and Regulatory Framework

Which regulatory body in the United States is responsible for approving new prescription medical devices before they can be marketed?

  1. The Federal Trade Commission (FTC)
  2. The Food and Drug Administration (FDA) Correct answer.
  3. The Centers for Medicare & Medicaid Services (CMS)
  4. The National Institutes of Health (NIH)

Explanation

The FDA has statutory authority to review and clear or approve medical devices for marketing through pathways such as 510(k) clearance, De Novo classification, and premarket approval. CMS governs payment and coverage, the FTC polices advertising, and NIH funds research, so none of those agencies grant marketing authorization.

Question 2Medical Review Fundamentals and Regulatory Framework

A device manufacturer wants to modify an already-cleared 510(k) device by changing its sterilization method. What is the most appropriate first step?

  1. Assess whether the change could significantly affect safety or effectiveness and document the decision Correct answer.
  2. Market the modified device immediately and notify the FDA afterward
  3. File a new investigational device exemption before any change
  4. Submit a full premarket approval application regardless of the change

Explanation

Under the Quality System Regulation and FDA guidance on 510(k) modifications, manufacturers must evaluate whether a change could significantly affect safety or effectiveness, then document that assessment. Only changes that cross that threshold require a new 510(k); minor changes may be handled internally.

Question 3Medical Review Fundamentals and Regulatory Framework

Which document defines the international standard for quality management systems of medical device manufacturers?

  1. ISO 9001
  2. ICH E6
  3. ISO 14971
  4. ISO 13485 Correct answer.

Explanation

ISO 13485 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices that consistently meet customer and regulatory requirements. ISO 9001 is the generic quality standard, ICH E6 covers good clinical practice, and ISO 14971 addresses risk management.

Question 4Medical Review Fundamentals and Regulatory Framework

A medical reviewer is evaluating a claim that a wound dressing reduces infection rates. Which evidence type provides the strongest support for a causal claim?

  1. A bench study showing the dressing absorbs fluid rapidly
  2. A retrospective case series from a single hospital
  3. Anecdotal clinician testimonials collected by the sponsor
  4. A randomized controlled trial with infection as a prespecified endpoint Correct answer.

Explanation

A randomized controlled trial with a prespecified clinical endpoint minimizes selection bias and supports causal inference about infection reduction. Testimonials, bench performance, and uncontrolled case series can suggest plausibility but cannot establish that the dressing itself caused lower infection rates.

Question 5Medical Review Fundamentals and Regulatory Framework

Under the FDA's risk-based device classification system, which class generally requires premarket approval because it supports or sustains life?

  1. Class II
  2. Class I
  3. Class III Correct answer.
  4. Class IV

Explanation

Class III covers devices that support or sustain human life, are of substantial importance in preventing impairment of health, or present a potential unreasonable risk of illness or injury, and these generally require premarket approval. Class I and II devices typically use general controls or 510(k) clearance, and there is no Class IV in the US system.

Question 6Medical Review Fundamentals and Regulatory Framework

A sponsor submits a premarket approval application. Which element is essential for the FDA to evaluate the device's safety and effectiveness?

  1. A list of competitor products
  2. A marketing budget projection
  3. Valid scientific evidence from nonclinical and clinical studies Correct answer.
  4. A summary of the company's organizational chart

Explanation

A PMA must contain valid scientific evidence demonstrating reasonable assurance of safety and effectiveness, drawn from nonclinical laboratory studies and clinical investigations. Business projections, competitor lists, and organizational charts are not evidence of safety or effectiveness.

Question 7Medical Review Fundamentals and Regulatory Framework

During review of a clinical investigation, a reviewer finds that informed consent forms omitted a known serious risk. What is the primary regulatory concern?

  1. The statistical analysis plan was not prespecified
  2. The sponsor's manufacturing facility lacks ISO certification
  3. The consent process failed to protect subject autonomy and may invalidate the study's ethical basis Correct answer.
  4. The device's sterility assurance level is inadequate

Explanation

Informed consent must disclose all known serious risks so that subjects can make an autonomous decision about participation. Omitting a serious risk undermines the ethical and regulatory validity of the study and may require corrective action or disqualification of the data.

Question 8Medical Review Fundamentals and Regulatory Framework

What is the primary purpose of a medical device recall?

  1. To punish the manufacturer for regulatory violations
  2. To remove or correct devices that violate regulations or present a health hazard Correct answer.
  3. To transfer liability from the manufacturer to clinicians
  4. To increase the market share of competing products

Explanation

A recall is a corrective action to remove from the market or correct devices that are defective or otherwise in violation of regulations and that may present a risk to health. Its purpose is public health protection, not punishment, market effects, or liability shifting.

Question 9Medical Review Fundamentals and Regulatory Framework

A reviewer notices that a sponsor's adverse event report was filed 45 calendar days after the sponsor became aware of a serious event. How should this be characterized?

  1. Timely, because serious events allow 60 days
  2. Timely, because only deaths require reporting
  3. Late, because serious adverse events require reporting within 30 calendar days Correct answer.
  4. Late, because all events require reporting within 10 working days

Explanation

Serious adverse events associated with an investigational device must be reported to the FDA and reviewing IRB within 30 calendar days of the sponsor becoming aware. A 45-day submission exceeds that window and is therefore late.

Question 10Medical Review Fundamentals and Regulatory Framework

Which principle from the Belmont Report requires that the burdens and benefits of research be distributed fairly?

  1. Beneficence
  2. Justice Correct answer.
  3. Respect for persons
  4. Integrity

Explanation

Justice requires fair distribution of the burdens and benefits of research across populations. Respect for persons addresses autonomy and informed consent, beneficence addresses risk-benefit balance, and integrity is not one of the three Belmont principles.

Question 11Medical Review Fundamentals and Regulatory Framework

A device is intended to diagnose a rare condition with no available alternative. Which regulatory mechanism is most appropriate to expedite patient access while generating evidence?

  1. Premarket Approval with no postmarket requirements
  2. Humanitarian Device Exemption Correct answer.
  3. 510(k) clearance based on a predicate device
  4. Enforcement discretion with no submission

Explanation

The Humanitarian Device Exemption allows marketing of a device intended to benefit patients with a rare disease or condition affecting fewer than 8,000 individuals in the US, subject to demonstrating safety and probable benefit. It is designed for small populations where full effectiveness data may be infeasible.

Question 12Medical Review Fundamentals and Regulatory Framework

What does the term 'predicate device' mean in the 510(k) process?

  1. A device used only in animal studies
  2. A legally marketed device to which substantial equivalence is claimed Correct answer.
  3. A device withdrawn from the market for safety reasons
  4. A prototype built before design freeze

Explanation

A predicate is a legally marketed device, often Class I or II and not subject to premarket approval, to which the submitter claims substantial equivalence. Animal-study devices, withdrawn devices, and prototypes are not valid predicates.

Question 13Medical Review Fundamentals and Regulatory Framework

A reviewer is assessing whether a diagnostic test's reported sensitivity of 99% is meaningful. Which factor is most important to examine alongside sensitivity?

  1. The number of patents held by the sponsor
  2. The prevalence of the condition in the tested population Correct answer.
  3. The manufacturer's advertising spend
  4. The color scheme of the device display

Explanation

Sensitivity and specificity depend on the population studied, and predictive values change markedly with disease prevalence. A high sensitivity in a selected high-prevalence sample may not translate to a low-prevalence screening population.

Question 14Medical Review Fundamentals and Regulatory Framework

Which document is the internationally recognized ethical and scientific quality standard for designing and conducting trials involving human subjects?

  1. ICH E6 Good Clinical Practice Correct answer.
  2. 21 CFR Part 11
  3. ISO 14971
  4. ISO 13485

Explanation

ICH E6 Good Clinical Practice is the international ethical and scientific quality standard for trials involving human subjects. ISO 14971 covers risk management, ISO 13485 covers quality systems, and 21 CFR Part 11 covers electronic records and signatures.

Question 15Medical Review Fundamentals and Regulatory Framework

A manufacturer receives multiple complaints about the same device failure but files no Medical Device Report. What regulatory requirement is most directly implicated?

  1. The requirement to obtain a new patent for the device
  2. The requirement to register as a 501(c)(3) nonprofit
  3. The requirement to publish all complaints in a peer-reviewed journal
  4. The requirement to report device-related deaths and serious injuries to the FDA Correct answer.

Explanation

Manufacturers must submit Medical Device Reports when they become aware of information suggesting a device may have caused or contributed to a death or serious injury, or malfunctioned in a way likely to cause harm. Accumulating complaints of the same failure can trigger this reporting duty.

Question 16Medical Review Fundamentals and Regulatory Framework

What is the role of an Institutional Review Board in device clinical research?

  1. To review and monitor research involving human subjects to protect their rights and welfare Correct answer.
  2. To set the reimbursement rate for the device
  3. To manufacture the investigational device
  4. To issue the patent for the device design

Explanation

An IRB reviews research protocols, consent forms, and continuing reports to ensure that human subjects' rights and welfare are protected. It does not manufacture devices, set reimbursement, or handle patents.

Question 17Medical Review Fundamentals and Regulatory Framework

A sponsor proposes to enroll prisoners in a trial of a device unrelated to their incarceration. Which regulatory position is most accurate?

  1. Enrollment is encouraged because prisoners are a captive population
  2. Enrollment is permitted without additional justification because consent is obtained
  3. Enrollment is prohibited in all circumstances without exception
  4. Enrollment is permitted only if the research presents no more than minimal risk and is otherwise permissible under the applicable subpart Correct answer.

Explanation

Research involving prisoners is permitted only under specific conditions, generally limited to minimal-risk studies of incarceration or the prison environment, or studies with a compelling public health rationale. The applicable subpart imposes strict additional safeguards rather than blanket prohibition or free enrollment.

Question 18Medical Review Fundamentals and Regulatory Framework

Which of the following best describes the purpose of the Unique Device Identification system?

  1. To replace the need for premarket submissions
  2. To set the price of a device in international markets
  3. To assign a unique number to each patient enrolled in a trial
  4. To provide a standardized identifier that improves traceability of devices through distribution and use Correct answer.

Explanation

The UDI system assigns a standardized identifier to devices and their packaging so they can be traced through distribution and use, supporting recalls and postmarket surveillance. It does not identify patients, substitute for premarket review, or set prices.

Question 19Medical Review Fundamentals and Regulatory Framework

A reviewer must determine whether a software feature qualifies as a medical device. Which criterion is most relevant?

  1. Whether the software is sold as a subscription
  2. Whether the software is intended to diagnose, treat, or prevent disease Correct answer.
  3. Whether the software was developed by a large company
  4. Whether the software is written in a popular programming language

Explanation

Device status turns on intended use: software intended for diagnosis, treatment, cure, or prevention of disease may meet the definition of a medical device. Language, company size, and business model do not determine regulatory status.

Question 20Medical Review Fundamentals and Regulatory Framework

What is the main function of a Corrective and Preventive Action system?

  1. To determine the reimbursement category for a device
  2. To investigate quality problems and prevent their recurrence Correct answer.
  3. To calculate the shelf life of a device
  4. To draft patent claims for new inventions

Explanation

A CAPA system identifies, investigates, and corrects quality problems and implements actions to prevent recurrence or occurrence. Shelf-life calculation, reimbursement categorization, and patent drafting fall outside its scope.

Question 21Medical Review Fundamentals and Regulatory Framework

A sponsor wants to use real-world data from electronic health records to support a new indication. Which consideration is most critical for regulatory acceptance?

  1. Whether the data include at least one million records
  2. Whether the sponsor owns the software used to extract the data
  3. Whether the data are fit for purpose, reliable, and relevant to the regulatory question Correct answer.
  4. Whether the data were collected in a hospital with a modern aesthetic

Explanation

Regulators evaluate real-world data on fitness for purpose, including data quality, reliability, and relevance to the specific regulatory question. Aesthetics, software ownership, and sheer volume do not substitute for fit-for-purpose evidence.

Question 22Medical Review Fundamentals and Regulatory Framework

Which of the following is a general control that applies to all medical devices regardless of class?

  1. Establishment registration and device listing Correct answer.
  2. Humanitarian Device Exemption
  3. Investigational device exemption
  4. Premarket approval

Explanation

General controls apply to all devices and include establishment registration, device listing, labeling requirements, and good manufacturing practice. Premarket approval, HDE, and IDE are specialized pathways that apply only in particular circumstances.

Question 23Medical Review Fundamentals and Regulatory Framework

A reviewer observes that a study's primary endpoint was changed after enrollment was complete. What is the most appropriate concern?

  1. The change may introduce bias and inflate the chance of a spurious positive result Correct answer.
  2. The change makes the study automatically invalid under all regulations
  3. The change means the device no longer requires a submission
  4. The change guarantees that the device is unsafe

Explanation

Changing a primary endpoint after enrollment can introduce bias and increase the likelihood of a false-positive finding, so such changes require strong justification and cautious interpretation. It does not automatically establish unsafety or invalidate the study under all rules.

Question 24Medical Review Fundamentals and Regulatory Framework

What does the term 'substantial equivalence' mean in the 510(k) process?

  1. The device has received premarket approval in another country
  2. The device is identical in every material and dimension to the predicate
  3. The device has been shown superior to the predicate in a randomized trial
  4. The device has the same intended use and similar technological characteristics as the predicate, with no different questions of safety and effectiveness Correct answer.

Explanation

Substantial equivalence means the new device has the same intended use and comparable technological characteristics as the predicate, such that it does not raise different questions of safety and effectiveness. Identical construction, demonstrated superiority, and foreign approval are not the standard.

Question 25Medical Review Fundamentals and Regulatory Framework

A device's labeling claims are broader than the evidence submitted in its marketing application. What is the most appropriate regulatory response?

  1. Accept the claims because labeling is not reviewed
  2. Refer the matter to the patent office for resolution
  3. Require the claims to be modified to conform to the evidence or supported by additional data Correct answer.
  4. Approve the claims but require a larger font size

Explanation

Labeling must be consistent with the intended use and supported by the evidence in the submission. Claims exceeding the evidence must be narrowed or substantiated with additional data before they can be permitted.

Question 26Medical Review Fundamentals and Regulatory Framework

Which regulatory pathway is generally required for a high-risk Class III device that has no legally marketed predicate and supports a new intended use?

  1. Investigational device exemption
  2. Premarket approval application Correct answer.
  3. 510(k) premarket notification
  4. Humanitarian device exemption

Explanation

A Class III device without a valid predicate and with a new intended use must generally go through the premarket approval process, which requires submission of clinical and nonclinical evidence of safety and effectiveness. The 510(k) route depends on comparison to a legally marketed predicate, and the humanitarian exemption is limited to rare-condition devices. An investigational device exemption permits study conduct but does not itself grant marketing authorization.

Question 27Medical Review Fundamentals and Regulatory Framework

Under the risk-based classification system, which factor most directly determines whether a device is assigned to Class I, II, or III?

  1. The cost of the device and its expected reimbursement status
  2. The country in which the device will be manufactured
  3. The size of the company that will market the device
  4. The degree of risk the device poses and the controls needed to ensure its safety and effectiveness Correct answer.

Explanation

Device classification is risk-based: the level of risk to patients and users, together with the regulatory controls necessary to assure safety and effectiveness, determines whether a device is Class I, II, or III. Commercial and organizational factors such as price, manufacturing location, and company size are not classification criteria. This risk framework allows controls to be proportionate to the potential harm.

Question 28Medical Review Fundamentals and Regulatory Framework

A reviewer is evaluating a proposed clinical study of an investigational device that presents significant risk to subjects. Which action must occur before enrollment begins?

  1. The sponsor must obtain FDA approval of an investigational device exemption and IRB approval Correct answer.
  2. The sponsor must file a premarket approval application before any subject is enrolled
  3. The sponsor must obtain only institutional review board approval because FDA review is not needed
  4. The sponsor must register the device in the unique device identification database first

Explanation

Significant-risk device studies require an approved investigational device exemption from FDA in addition to institutional review board approval before subjects are enrolled. IRB approval alone is insufficient for significant-risk studies, and marketing submissions are not prerequisites for beginning research. The IDE framework exists precisely to permit controlled investigation before marketing authorization.

Question 29Medical Review Fundamentals and Regulatory Framework

A reviewer is checking whether a device's promotional materials are consistent with its cleared indication. Which principle best guides the assessment?

  1. Claims must stay within the intended use and indications for use that the marketing authorization covers Correct answer.
  2. Claims may describe unapproved uses if a published study supports them
  3. Claims may be broadened once the device has been on the market for one year
  4. Claims may be expanded as long as a physician could reasonably infer the broader use

Explanation

A device may be promoted only for the intended use and indications for use that its marketing authorization covers. Promoting unapproved uses, even with supportive literature, exceeds the cleared or approved labeling and is not permitted. Market duration does not expand the authorized indications.

Question 30Medical Review Fundamentals and Regulatory Framework

During review, a reviewer must judge whether a device meets the statutory standard of reasonable assurance of safety and effectiveness. Which approach best reflects that standard?

  1. Deferring entirely to the clinical judgment of the treating physician
  2. Requiring proof that the device carries zero risk of serious adverse events in all patients
  3. Accepting the sponsor's internal bench data as sufficient without independent validation
  4. Weighing the probable benefits against the probable risks using valid scientific evidence for the intended population Correct answer.

Explanation

The statutory standard calls for a reasonable assurance that the device is safe and effective, which is assessed by weighing probable benefits against probable risks for the intended population using valid scientific evidence. Absolute zero risk is not the benchmark, and unverified sponsor data or individual physician judgment cannot substitute for adequate evidence. The judgment is population-based and evidence-driven.

Question 31Clinical Documentation and Medical Record Review

In a paper medical record, which entry is considered a late entry and must be clearly labeled as such?

  1. A discharge summary dictated on the day of discharge
  2. A pre-operative note written before the surgery begins
  3. A note added hours after the event it describes, with the actual date and time of writing Correct answer.
  4. A note written immediately after a procedure by the performing clinician

Explanation

A late entry is any documentation added after the fact rather than at the time of the event. It must be labeled as late and include the date and time the entry is actually written, plus the reason for the delay, so the record remains chronologically honest.

Question 32Clinical Documentation and Medical Record Review

Which abbreviation is on the Joint Commission do-not-use list because it can be misread as a number?

  1. U (for unit) Correct answer.
  2. MS (for morphine sulfate)
  3. cc (for cubic centimeter)
  4. Q.D. (for daily)

Explanation

The letter U can be mistaken for the numeral 0 or 4, so 'unit' must be written out in full. Q.D., MS, and cc are also error-prone abbreviations, but their risk is misreading as another word or dose rather than as a number.

Question 33Clinical Documentation and Medical Record Review

A physician writes an order for 'MS 2 mg IV.' According to safe-practice standards, what is the primary problem with this order?

  1. The dose of 2 mg exceeds the maximum single dose of every opioid
  2. The order lacks a patient weight and therefore cannot be given
  3. The route IV is inappropriate for all opioid analgesics
  4. The abbreviation MS is ambiguous and must be clarified before administration Correct answer.

Explanation

MS can stand for morphine sulfate or magnesium sulfate, two drugs with entirely different effects and risks. The nurse must contact the prescriber to clarify the intended drug before giving it. Ambiguous abbreviations are a leading cause of medication errors.

Question 34Clinical Documentation and Medical Record Review

Which element is required when correcting a handwritten error in a paper chart?

  1. A correction fluid applied so the error is fully hidden
  2. A single line through the error, the correction, and the initials and date Correct answer.
  3. A complete rewrite of the page with the error omitted
  4. An asterisk in the margin with no explanation

Explanation

Proper correction keeps the original entry legible while showing it was amended. Drawing one line through the error, writing the correct information, and adding initials and the date preserves the audit trail. Erasing or obliterating entries destroys the integrity of the record.

Question 35Clinical Documentation and Medical Record Review

A patient states that she takes 'a little white pill for her heart.' How should this be documented?

  1. Record it as digoxin because that is the most common white heart pill
  2. Record the patient's own words in quotation marks and note that the medication is unverified Correct answer.
  3. Record it as 'patient on cardiac medication, dose unknown'
  4. Omit the statement because it is not a verified medication

Explanation

Patient statements that cannot be verified should be recorded verbatim and labeled as unverified or per patient report. Assuming a specific drug introduces information that was never confirmed. Quoting the patient preserves accuracy without fabricating detail.

Question 36Clinical Documentation and Medical Record Review

Which of the following best describes the purpose of the medical record as a legal document?

  1. It serves mainly as a marketing tool for the facility
  2. It is kept only for billing and reimbursement purposes
  3. It replaces the need for informed consent discussions
  4. It provides a contemporaneous account that can be used to reconstruct care Correct answer.

Explanation

The medical record is the official, contemporaneous account of a patient's care and is admissible as evidence. Because it is created at the time of care, it can be used to reconstruct what happened. Documentation that is incomplete or altered undermines that legal function.

Question 37Clinical Documentation and Medical Record Review

What does the abbreviation 'SOAP' describe in clinical documentation?

  1. A note format with subjective, objective, assessment, and plan sections Correct answer.
  2. A method for sterilizing surgical instruments
  3. A coding system for billing diagnoses
  4. A regulatory agency that accredits hospitals

Explanation

SOAP is a structured progress-note format: subjective findings, objective data, assessment, and plan. It organizes clinical reasoning so other clinicians can follow the encounter quickly. It is a documentation structure, not a regulatory or billing system.

Question 38Clinical Documentation and Medical Record Review

A clinician realizes after a shift that a note omitted a critical allergy. What is the correct action?

  1. Delete the original note and create a new one
  2. Add a dated, signed addendum that clearly identifies the addition Correct answer.
  3. Rewrite the original note so the allergy appears in it
  4. Leave the record unchanged to avoid altering it

Explanation

An addendum is the appropriate way to supplement a completed note without altering the original. It must be dated, signed, and clearly identified as an addition. Rewriting or deleting the original destroys the integrity of the record.

Question 39Clinical Documentation and Medical Record Review

Which statement about documenting a patient's refusal of a recommended test is most accurate?

  1. Document the specific test refused, the reason given, and that risks were explained Correct answer.
  2. Do not document the refusal because the test was not performed
  3. Document only that the patient was noncompliant
  4. Document the refusal only in the billing record

Explanation

A refusal is a clinically significant event that belongs in the medical record. The note should identify what was refused, the patient's stated reason, and the discussion of risks and alternatives. This protects both the patient and the clinician.

Question 40Clinical Documentation and Medical Record Review

A note describes a patient as 'a 62-year-old pleasant white female with diabetes.' Which element is inappropriate in a clinical note?

  1. The reference to race Correct answer.
  2. The diabetes diagnosis
  3. The patient's age
  4. The patient's sex

Explanation

Race and ethnicity should be documented only when clinically relevant, not as part of a general description. Including it routinely can introduce bias and does not add clinical value. Age, sex, and diagnoses are standard, relevant elements.

Question 41Clinical Documentation and Medical Record Review

During review, a reviewer finds two notes with the same handwriting and signature but different names. What is the most appropriate concern?

  1. An acceptable practice when residents share duties
  2. Possible falsification or identity substitution requiring investigation Correct answer.
  3. A minor formatting issue that can be ignored
  4. A normal variation in physician signatures

Explanation

Different names with identical handwriting and signature suggest that one person signed for another, which is falsification. This must be referred for investigation because it compromises the authenticity of the record. Signature integrity is fundamental to attributing care.

Question 42Clinical Documentation and Medical Record Review

Which of the following is the best example of objective data in a progress note?

  1. Patient reports feeling anxious about the surgery
  2. Patient states the pain is unbearable
  3. Blood pressure 148/92 mm Hg and heart rate 96 beats per minute Correct answer.
  4. Patient appears worried about the upcoming procedure

Explanation

Objective data are measurable, observable findings such as vital signs and examination findings. Subjective data are what the patient reports or what the clinician infers about the patient's emotional state. Vital signs are reproducible measurements.

Question 43Clinical Documentation and Medical Record Review

A clinician documents 'patient is a drug seeker.' What is the primary documentation problem?

  1. It is a judgmental label that lacks objective clinical evidence Correct answer.
  2. It is too brief to be read by other clinicians
  3. It should be placed in the plan rather than the assessment
  4. It uses an unapproved abbreviation

Explanation

Stigmatizing labels are subjective judgments that can bias future caregivers and are not supported by objective findings. Documentation should describe specific behaviors and clinical data instead. Neutral, factual language protects both the patient and the record's credibility.

Question 44Clinical Documentation and Medical Record Review

In a hospital using electronic health records, what does 'copy-forward' or 'cloning' refer to?

  1. Copying a record to another facility on request
  2. Printing a note for the paper chart
  3. Carrying prior documentation into a new note without verifying it Correct answer.
  4. Backing up the record to a secure server

Explanation

Copy-forward is the practice of importing previous note content into a new entry. If the clinician does not review and update it, the record can contain outdated or inaccurate information. Many organizations require attestation that copied content was reviewed.

Question 45Clinical Documentation and Medical Record Review

A nurse documents an assessment at 14:00 but the electronic system timestamps the entry at 08:00 because the chart was opened earlier. What is the best action?

  1. Accept the system time because electronic timestamps are always accurate
  2. Delete the entry and re-enter it without any comment
  3. Correct the entry to reflect the actual time of assessment with an explanatory note Correct answer.
  4. Ask another nurse to sign the entry

Explanation

The documented time should reflect when the assessment actually occurred. If the system captures an inaccurate time, the clinician should correct it and explain the discrepancy. Accurate timing is essential for reconstructing the sequence of care.

Question 46Clinical Documentation and Medical Record Review

Which item is generally required for a complete operative report?

  1. Only the patient's discharge instructions
  2. Only the anesthesia record
  3. Preoperative and postoperative diagnoses, findings, and the procedure performed Correct answer.
  4. Only the name of the surgeon and the date

Explanation

An operative report must identify the procedure, the preoperative and postoperative diagnoses, the findings, and the details of what was done. These elements allow continuity of care and support quality review. A report with only names or dates is incomplete.

Question 47Clinical Documentation and Medical Record Review

A reviewer notes that the discharge summary was completed three weeks after discharge. Why is this a documentation concern?

  1. Discharge summaries have no deadline and timing is irrelevant
  2. Delayed summaries risk relying on memory and may omit care needed by follow-up providers Correct answer.
  3. The summary should only be written by the primary care physician
  4. A late summary is acceptable if it is signed

Explanation

Discharge summaries are meant to reach follow-up providers promptly and to be based on contemporaneous information. A summary written weeks later is more likely to contain errors or omissions. Timeliness is therefore a quality requirement, not merely a formality.

Question 48Clinical Documentation and Medical Record Review

What is the purpose of a 'time-out' note or checklist in procedural documentation?

  1. To document the surgeon's fee schedule
  2. To record the patient's insurance authorization
  3. To list the instruments used after the case
  4. To confirm patient identity, site, and procedure before starting Correct answer.

Explanation

The time-out is a brief pause before a procedure to verify the correct patient, site, and procedure. It is documented to show that the safety check occurred. This reduces wrong-site and wrong-patient errors.

Question 49Clinical Documentation and Medical Record Review

A patient's advance directive is scanned into the record, but the care team proceeds with interventions the directive prohibits. What documentation failure does this represent?

  1. Failure to complete the operative report
  2. Failure to document and communicate the patient's code status and directives Correct answer.
  3. Failure to obtain insurance preauthorization
  4. Failure to record vital signs at admission

Explanation

Advance directives must be documented in a way that is visible and acted upon by the care team. When a known directive is not reflected in the plan of care, the documentation and communication process has failed. Clear code status and directive documentation prevents unwanted interventions.

Question 50Clinical Documentation and Medical Record Review

Which of the following best reflects 'charting by exception'?

  1. Documenting every assessment in full narrative form
  2. Documenting only at discharge
  3. Documenting only findings that deviate from defined normal parameters Correct answer.
  4. Documenting only when a patient complains

Explanation

Charting by exception relies on predefined normal parameters; only abnormal or significant findings are documented in detail. It requires clear standards so that an omitted item means normal. This approach increases efficiency but depends on consistent definitions.